Genome.One is a pioneering health information company providing genetic answers to life's biggest health questions through clinically-accredited genomic analysis. We aim to enhance the lives of patients, families and communities across the world by enabling the future of precision healthcare.
Genome.One is a wholly owned subsidiary of the Garvan Institute of Medical Research.
Genome.One is developing an increasing portfolio of services and tools to enable precision healthcare, including: convenient and efficient analytical platforms for evaluation of cohort sequencing data, flexible diagnostic and prognostic genetic testing solutions, sophisticated applications that capture and securely share clinical data and highly accessible software interfaces.
Transforming lives through genomics.
By 2025, Genome.One technology and services will empower healthcare and lifestyle decision-making using genomic information - for millions of people, in Australia and across the world.